Atorvastatin ameliorates podocyte injury in patients with type 2 diabetes complicated with dyslipidemia

作者：Takemoto Minoru^*; Ishikawa Takahiro; Onishi Shunichiro; Okabe Emiko; Ishibashi Ryoichi; He Peng; Kobayashi Kazuki; Fujimoto Masaki; Kawamura Harukiyo; Yokote Koutaro

来源：Diabetes Research and Clinical Practice, 2013, 100(1): E26-E29.

DOI：10.1016/j.diabres.2012.12.018

• Statin
• Atorvastatin
• Rosuvastatin
• Diabetic nephropathy
• Podocyte
• Urinary podocyte

We examined the effects of atorvastatin on urinary podocyte excretion. Thirteen patients with type 2 diabetes receiving 2.5 mg of rosuvastatin were recruited and the medication was switched to 10 mg of atorvastatin for a 24-week period. With the switch to atorvastatin, the urinary excretion of podocytes was significantly reduced.

• 出版日期2013-4